Fields »
ABOUT
HELP
BLOG

290 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 6 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
KCNK17Potassium channel, two pore domain subfamily K, member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK3Potassium channel, two pore domain subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK4Potassium channel, two pore domain subfamily K, member 4Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK6Potassium channel, two pore domain subfamily K, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Plasma membrane
Actin filaments
Cytosol		Mixed
KCNK7Potassium channel, two pore domain subfamily K, member 7Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Voltage-gated ion channels
Plasma membraneTissue enriched
KCNK9Potassium channel, two pore domain subfamily K, member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNN1Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Actin filaments
Cytosol		Tissue enriched
KCNN3Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3Predicted membrane proteins
Voltage-gated ion channels
NucleoplasmTissue enhanced
KCNQ1Potassium channel, voltage gated KQT-like subfamily Q, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium channel, voltage gated KQT-like subfamily Q, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium channel, voltage gated KQT-like subfamily Q, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNQ4Potassium channel, voltage gated KQT-like subfamily Q, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNQ5Potassium channel, voltage gated KQT-like subfamily Q, member 5Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
VesiclesTissue enhanced
KCNS1Potassium voltage-gated channel, modifier subfamily S, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNV1Potassium channel, voltage gated modifier subfamily V, member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNV2Potassium channel, voltage gated modifier subfamily V, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KDELR2KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2Predicted membrane proteins
Expressed in all
LAPTM5Lysosomal protein transmembrane 5Predicted membrane proteins
Transporters
CytosolExpressed in all
LMF1Lipase maturation factor 1Disease related genes
Predicted membrane proteins
Expressed in all
MBOAT7Membrane bound O-acyltransferase domain containing 7Enzymes
Predicted membrane proteins
CytosolExpressed in all
MBTPS2Membrane-bound transcription factor peptidase, site 2Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Nucleoplasm
Mitochondria
Cytosol		Expressed in all
MCOLN2Mucolipin 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Intermediate filamentsMixed
MCOLN3Mucolipin 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoli
Cytosol		Tissue enhanced
MFSD12Major facilitator superfamily domain containing 12Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Mitochondria		Expressed in all
MFSD6Major facilitator superfamily domain containing 6Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Actin filaments
Cytosol		Expressed in all
MLC1Megalencephalic leukoencephalopathy with subcortical cysts 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
MMD2Monocyte to macrophage differentiation-associated 2Predicted membrane proteins
Group enriched
MPDU1Mannose-P-dolichol utilization defect 1Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Endoplasmic reticulum
Mitochondria		Expressed in all
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
MT-ND6Mitochondrially encoded NADH dehydrogenase 6Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Expressed in all
MYADMMyeloid-associated differentiation markerPredicted membrane proteins
Transporters
Nuclear specklesExpressed in all
NEMP1Nuclear envelope integral membrane protein 1Predicted membrane proteins
NucleoplasmMixed
NEMP2Nuclear envelope integral membrane protein 2Predicted intracellular proteins
Predicted membrane proteins
NucleoplasmMixed
NOX4NADPH oxidase 4Predicted membrane proteins
Transporters
NucleusTissue enriched
NPC1Niemann-Pick disease, type C1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
NPSR1Neuropeptide S receptor 1Disease related genes
G-protein coupled receptors
Potential drug targets
Predicted membrane proteins
Not detected
NRMNurim (nuclear envelope membrane protein)Predicted membrane proteins
Nuclear membraneMixed
OPRM1Opioid receptor, mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
P2RY6Pyrimidinergic receptor P2Y, G-protein coupled, 6G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PARLPresenilin associated, rhomboid-likeEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MitochondriaExpressed in all
PCNXL2Pecanex-like 2 (Drosophila)Predicted intracellular proteins
Predicted membrane proteins
Endoplasmic reticulumMixed
PGAP2Post-GPI attachment to proteins 2Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MicrotubulesExpressed in all
PGAP3Post-GPI attachment to proteins 3Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol		Expressed in all
PHTF2Putative homeodomain transcription factor 2Predicted membrane proteins
Transcription factors
Nucleoplasm
Cytosol		Mixed
PIGFPhosphatidylinositol glycan anchor biosynthesis, class FPredicted membrane proteins
Expressed in all
PIGOPhosphatidylinositol glycan anchor biosynthesis, class ODisease related genes
Predicted membrane proteins
Nucleus
Nucleoli		Expressed in all
PIGUPhosphatidylinositol glycan anchor biosynthesis, class UPredicted membrane proteins
Nucleoplasm
Cytosol		Expressed in all
PLPP4Phospholipid phosphatase 4Enzymes
Predicted membrane proteins
Nucleus
Nucleoli		Tissue enhanced
PLPP5Phospholipid phosphatase 5Enzymes
Predicted membrane proteins
VesiclesExpressed in all
PLPPR2Phospholipid phosphatase related 2Enzymes
Predicted membrane proteins
NucleoplasmExpressed in all

« prev | Page of 6 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.